Delivery Order SPE2DB22D1106-SPE2DB25FEFT4

Award Date 4/1/25
Potential Completion Date 4/22/25
Potential Value $21K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $20,473.22, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4567529401 HERCEPTIN 150 MG VIALS, a specialty medication. The contract has an ultimate completion date of March 31, 2025 and is a firm fixed-price type. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This federal contract award, with ID SPE2DB20D3103|SPE2DB22FN7X0, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $9,435.20 firm fixed price contract is for the delivery of Herceptin 150 mg vials, a specialty pharmaceutical used in cancer treatment. This delivery order was placed under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award is for the delivery of Herceptin 150 mg vials to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order with a ceiling value of $8,835.30 and a performance period through April 24, 2024. Amerisourcebergen Drug...
This federal contract award is for the delivery of HERCEPTIN 150 MG VIALS to the U.S. government. The contract, valued at $2,650.59, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 5, 2024, with a completion date of November 27, 2024. The contract is a delivery order with a firm-fixed price pricing type and was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. Amerisourcebergen Drug Corp also holds a significant...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at up to $2,650.59, is a Delivery Order for 4,564,660,776 units of the pharmaceutical product HERCEPTIN 150 MG VIALS. The contract has a Firm Fixed Price pricing type and a completion date of June 11, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract is for the delivery of 4,564,306,693 units of the drug Herceptin 150 mg vials, with a ceiling value of $21,204.72 and a completion date of May 8, 2024. Amerisourcebergen Drug Corp's Corporate Office Division holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of Herceptin 150 mg vials, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $2,650.59 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distributor, on October 28, 2022, with a completion date of November 19, 2024. The contract is not designated as a set-aside award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The $2,650.59 firm fixed-price delivery order is for the supply of 150 mg vials of the drug Herceptin. The contract has an ultimate completion date of November 5, 2024 and was awarded on October 15, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distribution company. The contract, valued at up to $5,301.18, is for the delivery of Herceptin 150 mg vials, a medication used to treat certain types of breast cancer. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,560.56, is for the delivery of Herceptin 150 mg vials, a specialty pharmaceutical product. The contract is a firm fixed-price delivery order, with a performance period extending through May 27, 2025. It is not set aside for any specific business category. Amerisourcebergen Drug...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FEFT4
    Delivery Order

This federal contract award, with ID SPE2DB22D1106|SPE2DB25FEFT4, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $21,363.36 firm fixed-price delivery order is for the supply of HERCEPTIN 150 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of April 22, 2025.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

This contract award was not designated with any set-aside requirements, indicating open competition.

Generated 7/1/25, 8:38 AM